- Home
- GASS vs IMMP Comparison
GASS vs IMMP Comparison
Compare GASS & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GASS
- IMMP
- Stock Information
- Founded
- GASS 2004
- IMMP 1987
- Country
- GASS Greece
- IMMP Australia
- Employees
- GASS N/A
- IMMP N/A
- Industry
- GASS Marine Transportation
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- GASS Consumer Discretionary
- IMMP Health Care
- Exchange
- GASS Nasdaq
- IMMP Nasdaq
- Market Cap
- GASS 204.1M
- IMMP 211.1M
- IPO Year
- GASS 2005
- IMMP N/A
- Fundamental
- Price
- GASS $5.37
- IMMP $1.85
- Analyst Decision
- GASS
- IMMP Buy
- Analyst Count
- GASS 0
- IMMP 2
- Target Price
- GASS N/A
- IMMP $8.50
- AVG Volume (30 Days)
- GASS 61.0K
- IMMP 645.2K
- Earning Date
- GASS 05-21-2025
- IMMP 05-16-2025
- Dividend Yield
- GASS N/A
- IMMP N/A
- EPS Growth
- GASS 38.46
- IMMP N/A
- EPS
- GASS 1.90
- IMMP N/A
- Revenue
- GASS $167,262,185.00
- IMMP $3,019,249.00
- Revenue This Year
- GASS N/A
- IMMP $11.25
- Revenue Next Year
- GASS $3.49
- IMMP $10.22
- P/E Ratio
- GASS $2.84
- IMMP N/A
- Revenue Growth
- GASS 16.54
- IMMP 24.11
- 52 Week Low
- GASS $4.82
- IMMP $1.32
- 52 Week High
- GASS $8.84
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- GASS 49.36
- IMMP 53.09
- Support Level
- GASS $5.30
- IMMP $1.44
- Resistance Level
- GASS $5.57
- IMMP $2.71
- Average True Range (ATR)
- GASS 0.16
- IMMP 0.18
- MACD
- GASS 0.02
- IMMP 0.03
- Stochastic Oscillator
- GASS 68.25
- IMMP 28.93
About GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.